Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Narjes

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Acta Psychiatrica Belgica|January 1, 1987
[Address at the academic session of the creation of the European College of Neuropsychopharmacology]K H Narjes
European Journal of Clinical Pharmacology|August 23, 2000
Effect of hospitalisation on liver enzymes in healthy subjectsH Narjes, G Nehmiz
European Journal of Clinical Pharmacology|January 1, 1995
The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in manU Busch, G Heinzel, H Narjes
Arzneimittel-Forschung|March 1, 1997
Clinical pharmacokinetics of meloxicamD Türck, U Busch, G Heinzel, et al.
Journal of Clinical Pharmacology|January 1, 1996
Interaction of meloxicam with cimetidine, Maalox, or aspirinU Busch, G Heinzel, H Narjes, et al.
British Journal of Clinical Pharmacology|November 1, 1995
The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxinF L Degner, G Heinzel, H Narjes, et al.
British Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics and tolerability of meloxicam after i.m. administrationH Narjes, D Türck, U Busch, et al.
Journal of Clinical Pharmacology|January 1, 1997
Inhibition of platelet aggregation as a surrogate markerH Narjes, T H Müller, H Weisenberger, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteersD Türck, A Schwarz, D Höffler, et al.
British Journal of Clinical Pharmacology|July 25, 2000
Absorption of lefradafiban from different sites of the gastrointestinal tractJ Drewe, H Narjes, G Heinzel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Acta Psychiatrica Belgica|January 1, 1987
[Address at the academic session of the creation of the European College of Neuropsychopharmacology]K H Narjes
European Journal of Clinical Pharmacology|August 23, 2000
Effect of hospitalisation on liver enzymes in healthy subjectsH Narjes, G Nehmiz
European Journal of Clinical Pharmacology|January 1, 1995
The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in manU Busch, G Heinzel, H Narjes
Arzneimittel-Forschung|March 1, 1997
Clinical pharmacokinetics of meloxicamD Türck, U Busch, G Heinzel, et al.
Journal of Clinical Pharmacology|January 1, 1996
Interaction of meloxicam with cimetidine, Maalox, or aspirinU Busch, G Heinzel, H Narjes, et al.
British Journal of Clinical Pharmacology|November 1, 1995
The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxinF L Degner, G Heinzel, H Narjes, et al.
British Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics and tolerability of meloxicam after i.m. administrationH Narjes, D Türck, U Busch, et al.
Journal of Clinical Pharmacology|January 1, 1997
Inhibition of platelet aggregation as a surrogate markerH Narjes, T H Müller, H Weisenberger, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteersD Türck, A Schwarz, D Höffler, et al.
British Journal of Clinical Pharmacology|July 25, 2000
Absorption of lefradafiban from different sites of the gastrointestinal tractJ Drewe, H Narjes, G Heinzel, et al.
Pageof 2